The Olanzapine Tablets, cataloged under National Stock Number 6505-01-726-6687, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Apotex Corp. Dba Apotex Corp. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-726-6687 |
| Primary Part Number | NDC60505-3276-03 |
| Item Name | Olanzapine Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Apotex Corp. Dba Apotex Corp |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 30.0 TABLETS |
| Primary Container Type | BOTTLE |
| Total Primary Container Quantity | 30 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC51407-0262-30 | Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc (USA) |
| NDC60505-3276-03 PRIMARY | Apotex Corp. Dba Apotex Corp (USA) |
| Reference | Meaning |
|---|---|
| 1682216 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM251227 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-726-6687 is a Olanzapine Tablets, manufactured by Apotex Corp. Dba Apotex Corp, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-726-6687 has 2 manufacturer part numbers on file: NDC51407-0262-30 (Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc), NDC60505-3276-03 (Apotex Corp. Dba Apotex Corp).
Key specifications for NDC60505-3276-03: Administration: ORAL; Primary Container Content Quantity: 30.0 TABLETS; Primary Container Type: BOTTLE; Special Features: OLANZAPINE TABLETS 10MG ORALLY DISINTEGRATING TABLETS (ODT) BOTTLE OF 30S. STORE AT CONTROLLED ROOM TEMPERATURE 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED FROM 15 C TO 30 C (59 F TO 86 F). PROTECT FROM LIGHT AND MOISTURE.. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.